Construction of a pathway-level model for preeclampsia based on gene expression data

Andong He,Ka Cheuk Yip,Daiqiang Lu,Jia Liu,Zunhao Zhang,Xiufang Wang,Yifeng Liu,Yiling Wei,Qiao Zhang,Ruiling Yan,Feng Gao,Ruiman Li

DOI: https://doi.org/10.1038/s41440-024-01753-0

2024-06-25

Hypertension Research

Abstract:Preeclampsia (PE) is a heterogeneous disease that seriously affects the health of mothers and fetuses. Lack of detection assays, its diagnosis and intervention are often delayed when the clinical symptoms are atypical. Using personalized pathway-based analysis and machine learning algorithms, we built a PE diagnosis model consisting of nine core pathways using multiple cohorts from the Gene Expression Omnibus database. The model showed an area under the receiver operating characteristic (AUROC) curve of 0.959 with the data from the placental tissue samples in the development cohort. In the two validation cohorts, the AUROCs were 0.898 and 0.876, respectively. The model also performed well with the maternal plasma data in another validation cohort (AUROC: 0.815). Moreover, we identified tyrosine-protein kinase Lck (LCK) as the hub gene in this model and found that LCK and pLCK proteins were downregulated in placentas from PE patients. The pathway-level model for PE can provide a novel direction to develop molecular diagnostic assay and investigate potential mechanisms of PE in future studies.

peripheral vascular disease